Arbutus Biopharma (ABUS) Finished Goods (2010)
Arbutus Biopharma (ABUS) posted quarterly Finished Goods of $148751.7 for Q4 2010.
Arbutus Biopharma (ABUS) Finished Goods (2010) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Finished Goods for 1 consecutive years, with $148751.7 the latest figure, recorded in Q4 2010.
- Quarterly Finished Goods changed N/A year-over-year to $148751.7 in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $148751.7 (changed N/A YoY) and the FY2010 annual result came in at $148751.7, changed N/A from the prior year.
- Finished Goods steadied at $148751.7 in Q4 2010 per ABUS's latest filing.
- Over the last five years, Finished Goods for ABUS reached as high as $148751.7 in Q4 2010 and fell as low as $148751.7 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 148,751.65 |